CLINICAL_TRIALS
trial_result
· 2020-03-20
Clinical Trial Update: Pharmacokinetics of Voxilaprevir in Adults With Normal Renal Function and Severe Renal Impairment [Phase 1]
Summary
Phase 1 pharmacokinetics study of Voxilaprevir in adults with normal renal function and severe renal impairment; results completed and posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: HCV Infection | Phase 1 | Status: COMPLETED | Results posted: 2020-03-20